TBXAS1 and atherosclerosis: Specifically in ApoE-KO mice, BM-573, but not ASA, significantly decreased atherosclerotic lesions formation, showing that a dual TxAS inhibition and TP receptor antagonism is more effective in delaying atherosclerosis than single inhibition of TxA2 formation.